BSX CEO Buys 350K Shares

Boston Scientific CEO James Tobin exercised $2.1 million worth of options on shares of the Natick, MA-based medical device firm yesterday as an “an expression of confidence in the company,” according to a report in the Boston Business Journal. The CEO’s purchase of 350,000 shares of Boston Scientific (NYTS:[[ticker:BSX]]) stock at $6.13 per share followed on the heels of co-founders Pete Nicholas and John Abele’s involuntary sale of about about 13 million shares as part of an automatic selling plan. Shares of Boston Scientific are trading at $7.31 at around 1:00 pm EST; the 52-week low for the stock is $8.10.

Author: Rebecca Zacks

Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University. View all posts by Rebecca Zacks